loaderimg
image

In May of 2012, CryoLife acquired Hemosphere, Inc. Hemosphere manufactures the HeRO® (Hemodialysis Reliable Outflow) Graft, which is a vascular access device for use in hemodialysis for patients with end-stage renal disease. The HeRO Graft is the ONLY fully subcutaneous AV access solution clinically proven to maintain long term access for hemodialysis patients with central venous stenosis.

Company’s Keywords:

Q How Many Employees Does This Company Have?

<5

Q Which Industry Does This Company Belong To?

Q What Is the Annual Income?

<4806000

Q What Is the Technology of All the Company’s Website?

<

Q What Year Was the Company Founded?

<1984

Rate us and Write a Review

Your review is recommended to be at least 140 characters long

image

building Own or work here? Claim Now! Claim Now!

imageYour request has been submitted successfully.

image